{"id":"559239-9520","orgnr":"559239-9520","name":"ClinQ AB","name_registered_on":"2020-02-03","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2020-02-03","business_description":"Företaget ska bedriva handel med konsultverksamhet inom läkemedelsindustrin beträffande kliniska prövningar. Verksamhet kommer att vara inriktad på att hjälpa företag med deras kvalitetssystem och kvalitetssäkring. Dessutom kommer företaget att bedriva utbildning inom detta område","industries":[{"code":"70200","name":"Konsultverksamhet avseende företags organisation"}],"postal_address":{"city":"HELSINGBORG","country":"SE","municipality":{"code":"1283","name":"Helsingborg"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1283","name":"Helsingborg"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-03-18","documents":{"annual_report":"/v1/documents/82fad34c-1849-460b-a5f1-7731cb47441e.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/12_4.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-04-08","documents":{"annual_report":"/v1/documents/0ad2cabb-a083-47e2-9414-07dc0488b161.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/20_6.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-04-22","documents":{"annual_report":"/v1/documents/cf34e3ba-59ea-42e1-b7e4-e477ad6dcfef.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/25_6.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-03-14","documents":{"annual_report":"/v1/documents/a83d95e7-e239-4413-a34f-475ea2f26579.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/14_3.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-05-10","documents":{"annual_report":"/v1/documents/661d04a9-0fae-497f-9042-47644acd235c.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/19_2.zip"}},{"from":"2020-02-03","to":"2020-12-31","framework":"K2","signed_on":"2021-06-30","documents":{"annual_report":"/v1/documents/d710be87-ae53-4e26-875b-bc0ddf3e809b.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/28_4.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-23189,"profit_after_financial_items":-22196,"net_profit":59067,"total_assets":892759,"current_assets":192759,"equity":493593,"share_capital":25000,"unrestricted_equity":468593,"untaxed_reserves":373000,"current_liabilities":26166,"tax_liabilities":6472,"cash":192088,"equity_ratio":0.89,"source":{"annual_report":"2025-12-31","document":"/v1/documents/82fad34c-1849-460b-a5f1-7731cb47441e.xhtml"},"anchors":{"cash":{"text":"192 088","prefix":"Summa kassa och bank","suffix":"1 119 009"},"current_assets":{"text":"192 759"},"current_liabilities":{"text":"26 166"},"equity":{"text":"493 593"},"equity_ratio":{"text":"89","prefix":"Soliditet %"},"net_profit":{"text":"59 067","suffix":"25"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"profit_after_financial_items":{"text":"22 196"},"share_capital":{"text":"25 000","prefix":"utgång"},"tax_liabilities":{"text":"6 472"},"total_assets":{"text":"892 759","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"468 593","suffix":"Styrelsen"},"untaxed_reserves":{"text":"373 000","prefix":"reserver"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-03-18","signatories":[{"name":"A*****"}]}}